Thymmune Therapeutics Inc

Biotechnology company · Cambridge, Massachusetts, United States

Thymmune Therapeutics Inc is a biotechnology company headquartered in Cambridge, Massachusetts, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.6 million in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Thymmune Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Employees (self-reported, 2024)6

What does Thymmune Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $2.6 million in total (2022 to 2024). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Frequently asked questions about Thymmune Therapeutics

Where is Thymmune Therapeutics headquartered?

Thymmune Therapeutics Inc is headquartered in Cambridge, Massachusetts, United States.

What does Thymmune Therapeutics do?

Thymmune Therapeutics Inc is a biotechnology company.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences